Ariel Nash, MD
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Pediatrics - Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2018 | Virginia Commonwealth University School of Medicine, Richmond, Virginia, US, Doctor of Medicine |
| 2014 | University Honors Virginia Commonwealth University, Richmond, Virginia, US, Concentration in Biochemistry, Bachelor of Science in Chemistry |
Postgraduate Training
| 2022-2025 | Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2018-2022 | Internal Medicine, Pediatric Residency, Albany Medical Center, Albany, New York |
Licenses & Certifications
| 2023 | American Board of Internal Medicine |
| 2023 | Texas Medical License |
| 2022 | American Board of Pediatrics |
Experience & Service
Other Professional Positions
Chief Fellow, Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - 2025
Clinical Research Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Fellow, Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present
Chief Resident, Albany Medical Center, Albany, New York, 2021 - 2022
Medicine - Pediatric Resident, Albany Medical Center, Albany, 2018 - 2022
Extramural Institutional Committee Activities
Faculty Member, Pediatric Clinical Practice Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Clinical Fellow Collaborator, Biospecimens Team, The University of Texas MD Anderson Cancer Center, 2023 - Present
Secretary, House Staff Senate, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Co-Team Lead, Education Team, The University of Texas MD Anderson Cancer Center, 2023 - Present
Fellow Member, Pediatric Clinical Practice Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2025
Fellow Member, Pediatric Education Council, The University of Texas MD Anderson Cancer Center, 2022 - Present
Resident Representative, American Academy of Pediatrics (AAP), Albany Medical Center, 2020 - 2021
Resident Member, Internal Medicine Residency Council, Albany Medical Center, 2019 - 2021
Resident Member, Graduate Medical Education (GME) Council, Albany Medical Center, 2019 - 2022
Resident Representative, National Med-Peds Residents’ Association (NMPRA), Albany Medical Center, 2019 - 2020
Resident Member, Baby Institute, Albany Medical Center, 2019 - 2022
Honors & Awards
| 2025 - Present | Excellence in Research, First Place Presentation, UT Health Annual Pediatric Fellows Research Symposium |
| 2025 - Present | Peer of the Year Award, The University of Texas at MD Anderson Cancer Center |
| 2025 - Present | Nursing’s Outpatient Fantastic Fellow Award, The University of Texas at MD Anderson Cancer Center |
| 2025 - Present | Outstanding Excellence recognized through Awesome Job Awards, The University of Texas at MD Anderson Cancer Center |
| 2023 - Present | Outstanding Performance in Non-Neural Solid Tumors, The University of Texas at MD Anderson Cancer Center |
| 2019 - Present | Winner of NMRPA Resident Clinical Case Competition, NMPRA Annual Conference |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2024. A Rare Presentation of Hodgkin Lymphoma Presenting with Elevated AFP. Poster. Children’s Oncology Group- Fall Meeting. New Orleans, Louisiana, US.
- 2024. Use of Immunotherapy and Targeted Therapy in EPOR-IGH B-ALL. Poster. Children's Oncology Group - Fall Meeting. New Orleans, Louisiana, US.
- 2024. Harmonizing Cancer Care Delivery for AYAs with Osteosarcoma: Comparison of Pediatric and Medical Oncology Approaches in a Single Center. Poster. American Society of Clinical Oncology Annual Meeting. Chicago, Illinois, US.
- 2024. A case report on novel combination therapy in a pediatric patient with CLL. Poster. American Society of Pediatric Hematology/Oncology Annual Meeting. Seattle, Washington, US.
- 2024. Improving handoff documentation through the EHR: A Quality Improvement project. Poster. American Society of Pediatric Hematology/Oncology Annual Meeting. Seattle, Washington, US.
- 2023. Hemolytic Anemia as an Atypical Delayed Hypersensitivity Reaction to Calasparagase Pegol. Poster. Children's Oncology Group - Fall Meeting. Atlanta, Georgia, US.
- 2023. Pediatric Pure Erythroid Leukemia- An Ongoing Diagnostic and Therapeutic Conundrum. Poster. American Society of Pediatric Hematology/Oncology. Fort Worth, Texas, US.
- 2019. Vitamin B12 Deficiency, Not a Laughing Matter. Poster. 52nd Annual NMPRA Conference, US.
Selected Publications
Peer-Reviewed Articles
- Patel B, Zheng X, Kahn LM, Schneider SM, Pineda JE, Riba MN, Ouchen K, Meril S, Nash AP, Wang J, Watowich SS. STAT3 mediates an inflammation-induced microbial defense response and regulates pathogen control and clearance by macrophages. J Immunol, 2025. e-Pub 2025. PMID: 41216965.
- Nash AP, Harden A, Sheth RK. The Ethical Complexity of Medical Decision Making in the Adolescent Oncology Patient. Curr Oncol 31(8):4158-4164, 2024. e-Pub 2024. PMID: 39195293.
- Nash AP, Ye D. Silver coated nickel nanotip arrays for low concentration surface enhanced Raman scattering. J Appl Phys, 2015. e-Pub 2015.
Letters to the Editor
- Nash A, Dinh CN, Kawedia J, McCall D, Weinman S, Garcia M, Roth M, Nunez C, Cuglievan B, Gibson A. Calasparagase Pegol Induced Hemolytic Anemia. Pediatr Blood Cancer, 2025.
- Nash A, Weirda W, Albritton K, Cuglievan B, Garcia M, McCall D, Nunez C, Gibson A. Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy. Pediatr Blood Cancer, 2024.
Patient Reviews
CV information above last modified March 19, 2026